New York State and California’s nationally watched efforts to transfer their pharmacy programs for low-income individuals from Medicaid managed care to Medicaid fee for service (FFS)—both scheduled to take effect on April 1—have been temporarily placed on hold. The states
…Articles by : Tom Mirga, Editor at Large
Two hundred and twenty six U.S. House members—173 Democrats and 57 Republicans—have signed a letter to U.S. Health and Human Services (HHS) Acting Secretary Norris Cochran asking him “to take immediate action to ensure that manufacturers are prohibited from imposing
…
340B covered entities say they are deeply concerned about pharmacy benefit manager Express Scripts’ (ESI) requirements, effective Monday, governing what pharmacies in the PBM’s network must do when they identify that a previously submitted claim is 340B-eligible. Last night, ESI told
…
Today is the deadline for U.S. House members to sign a bipartisan letter asking U.S. Health and Human Services Department (HHS) leaders to act against drug manufacturers denying 340B pricing on drugs, to halt attempts to turn 340B into a
…
Xavier Becerra, President Biden’s pick to be the next U.S. Health and Human Services (HHS) Secretary survived his U.S. Senate Finance Committee confirmation hearing yesterday, with a GOP foe of his nomination grudgingly predicting the panel would vote to confirm
…
Pharmacy benefit manager Express Scripts late yesterday began notifying 340B covered entities by email that, effective March 1, it “will require a new identification method for submitting and identifying 340B eligible claims.”
A health system 340B program manager said this
…Hospitals, Health Centers, and HIV/AIDS Clinics Want Roles in Lilly’s 340B Contract Pharmacy Lawsuit
The hospital groups that last week lost a federal lawsuit in California to make federal health officials enforce 340B contract pharmacy requirements for drug manufacturers have asked a federal court in Indiana to make them parties in opposition to manufacturer
…
The U.S. Senate Finance Committee’s new Democratic chair is considering bringing back a bipartisan bill from the last session of Congress that would require drug manufacturers to pay the federal government rebates on Medicare Part B and Part D drugs
…
Thirty-six state and regional hospital associations on Tuesday urged the U.S. Supreme Court to overturn a federal appeals court’s 2-1 July 2020 decision that upheld the nearly 30 percent cut since 2018 in 340B hospitals’ drug reimbursement under the hospital
…